Imidazole → HCID 68453232, Verbindung
Reaktionsgleichung
[OH:1][C:2]1[CH:3]=[CH:4][C:5]([I:12])=[C:6]2[C:11]=1[N:10]=[CH:9][CH:8]=[CH:7]2.N1C=CN=C1.[Si:18](Cl)([C:21]([CH3:24])([CH3:23])[CH3:22])([CH3:20])[CH3:19]>C(Cl)Cl>[Si:18]([O:1][C:2]1[CH:3]=[CH:4][C:5]([I:12])=[C:6]2[C:11]=1[N:10]=[CH:9][CH:8]=[CH:7]2)([C:21]([CH3:24])([CH3:23])[CH3:22])([CH3:20])[CH3:19]Komponenten
5
Edukt 3
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
8-Hydroxy-5-iodoquinoline (7.0 g, 25.8 mmol), imidazole (1.85 g, 27.2 mmol) and tert-butyldimethylsilyl chloride (4.28 g, 28.4 mmol) are dissolved in anhydrous CH2Cl2 (40 ml) under N2. The mixture is stirred vigorously overnight, then diluted with CH2Cl2 (60 ml) and washed with 5% aqueous HCl (2×30 ml) and water (40 ml). The organic phase is dried over sodium sulfate, and the solvent is distilled off under reduced pressure, leaving a brown liquid. This crude product is purified by flash chromatography on silica (heptane:ethyl acetate 5:1). The end product is isolated as pale-yellow solid (8 g, 80%).
Aufarbeitung
- washwashed with 5% aqueous HCl (2×30 ml) and water (40 ml)
- dry with materialThe organic phase is dried over sodium sulfate
- distillationthe solvent is distilled off under reduced pressure
- customleaving a brown liquid
- customThis crude product is purified by flash chromatography on silica (heptane:ethyl acetate 5:1)
Quellen und Nachweise
- ORD-Eintrag
- ord-ef1368c8e3464ea6b05b10c1d4b12eeb
- Quelldatensatz
- uspto-grants-2016_08
- Patentnummer
- US09409883B2
Notizen zur Reaktion
Wird geladen…